US Stock MarketDetailed Quotes

ENLV Enlivex Therapeutics

Watchlist
  • 1.182
  • -0.029-2.36%
Trading Dec 13 13:45 ET
25.98MMarket Cap-1.21P/E (TTM)

Enlivex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-44.58%3.12M
-55.09%2.99M
-41.77%3.95M
-2.50%25.15M
-22.36%6.09M
-0.86%5.63M
13.25%6.65M
5.92%6.78M
33.75%25.8M
0.40%7.85M
Selling and administrative expenses
-39.72%771K
-38.85%987K
-31.99%1.09M
-21.92%5.23M
-57.95%733K
-13.35%1.28M
-8.35%1.61M
-6.68%1.61M
7.40%6.7M
-29.75%1.74M
-General and administrative expense
-39.72%771K
-38.85%987K
-31.99%1.09M
-21.92%5.23M
-57.95%733K
-13.35%1.28M
-8.35%1.61M
-6.68%1.61M
7.40%6.7M
-29.75%1.74M
Research and development costs
-46.01%2.35M
-60.30%2M
-44.80%2.86M
1.71%19.01M
-21.89%4.45M
3.52%4.35M
22.51%5.04M
10.55%5.18M
45.12%18.69M
10.34%5.7M
Other operating expenses
----
----
----
125.37%906K
----
----
----
----
140.72%402K
----
Operating profit
44.58%-3.12M
55.09%-2.99M
41.77%-3.95M
2.50%-25.15M
22.36%-6.09M
0.86%-5.63M
-13.25%-6.65M
-5.92%-6.78M
-33.75%-25.8M
-0.40%-7.85M
Net non-operating interest income expense
254.33%517K
23.08%-110K
102.53%11K
88.92%1.55M
2.46M
-335K
-143K
-435K
494.71%821K
Non-operating interest income
----
----
----
87.43%1.57M
----
----
----
----
595.83%835K
----
Total other finance cost
-254.33%-517K
-23.08%110K
-102.53%-11K
0.00%14K
---899K
--335K
--143K
--435K
-95.73%14K
----
Other net income (expense)
-201K
10.12%-5.47M
-221.00%-6.08M
-105.02%-165K
Gain on sale of security
----
----
----
79.88%-1.22M
----
----
----
----
-221.00%-6.08M
----
Special income (charges)
--0
--0
---201K
---4.24M
---4.24M
--0
--0
--0
--0
----
-Gain on sale of property,plant,equipment
--0
--0
---201K
---4.24M
---4.24M
--0
--0
--0
--0
----
Income before tax
56.36%-2.6M
54.42%-3.1M
42.64%-4.14M
6.41%-29.07M
-26.51%-9.1M
-4.01%-5.96M
31.48%-6.79M
12.24%-7.22M
-114.68%-31.06M
-51.79%-7.19M
Income tax
Net income
56.36%-2.6M
54.42%-3.1M
42.64%-4.14M
6.41%-29.07M
-26.51%-9.1M
-4.01%-5.96M
31.48%-6.79M
12.24%-7.22M
-114.68%-31.06M
-51.79%-7.19M
Net income continuous Operations
56.36%-2.6M
54.42%-3.1M
42.64%-4.14M
6.41%-29.07M
-26.51%-9.1M
-4.01%-5.96M
31.48%-6.79M
12.24%-7.22M
-114.68%-31.06M
-51.79%-7.19M
Minority interest income
Net income attributable to the parent company
56.36%-2.6M
54.42%-3.1M
42.64%-4.14M
6.41%-29.07M
-26.51%-9.1M
-4.01%-5.96M
31.48%-6.79M
12.24%-7.22M
-114.68%-31.06M
-51.79%-7.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
56.36%-2.6M
54.42%-3.1M
42.64%-4.14M
6.41%-29.07M
-26.51%-9.1M
-4.01%-5.96M
31.48%-6.79M
12.24%-7.22M
-114.68%-31.06M
-51.79%-7.19M
Basic earnings per share
62.50%-0.12
56.76%-0.16
43.59%-0.22
7.69%-1.56
-23.08%-0.48
-3.23%-0.32
31.48%-0.37
13.33%-0.39
-108.64%-1.69
-44.44%-0.39
Diluted earnings per share
62.50%-0.12
56.76%-0.16
43.59%-0.22
7.69%-1.56
-23.08%-0.48
-3.23%-0.32
31.48%-0.37
13.33%-0.39
-108.64%-1.69
-44.44%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -44.58%3.12M-55.09%2.99M-41.77%3.95M-2.50%25.15M-22.36%6.09M-0.86%5.63M13.25%6.65M5.92%6.78M33.75%25.8M0.40%7.85M
Selling and administrative expenses -39.72%771K-38.85%987K-31.99%1.09M-21.92%5.23M-57.95%733K-13.35%1.28M-8.35%1.61M-6.68%1.61M7.40%6.7M-29.75%1.74M
-General and administrative expense -39.72%771K-38.85%987K-31.99%1.09M-21.92%5.23M-57.95%733K-13.35%1.28M-8.35%1.61M-6.68%1.61M7.40%6.7M-29.75%1.74M
Research and development costs -46.01%2.35M-60.30%2M-44.80%2.86M1.71%19.01M-21.89%4.45M3.52%4.35M22.51%5.04M10.55%5.18M45.12%18.69M10.34%5.7M
Other operating expenses ------------125.37%906K----------------140.72%402K----
Operating profit 44.58%-3.12M55.09%-2.99M41.77%-3.95M2.50%-25.15M22.36%-6.09M0.86%-5.63M-13.25%-6.65M-5.92%-6.78M-33.75%-25.8M-0.40%-7.85M
Net non-operating interest income expense 254.33%517K23.08%-110K102.53%11K88.92%1.55M2.46M-335K-143K-435K494.71%821K
Non-operating interest income ------------87.43%1.57M----------------595.83%835K----
Total other finance cost -254.33%-517K-23.08%110K-102.53%-11K0.00%14K---899K--335K--143K--435K-95.73%14K----
Other net income (expense) -201K10.12%-5.47M-221.00%-6.08M-105.02%-165K
Gain on sale of security ------------79.88%-1.22M-----------------221.00%-6.08M----
Special income (charges) --0--0---201K---4.24M---4.24M--0--0--0--0----
-Gain on sale of property,plant,equipment --0--0---201K---4.24M---4.24M--0--0--0--0----
Income before tax 56.36%-2.6M54.42%-3.1M42.64%-4.14M6.41%-29.07M-26.51%-9.1M-4.01%-5.96M31.48%-6.79M12.24%-7.22M-114.68%-31.06M-51.79%-7.19M
Income tax
Net income 56.36%-2.6M54.42%-3.1M42.64%-4.14M6.41%-29.07M-26.51%-9.1M-4.01%-5.96M31.48%-6.79M12.24%-7.22M-114.68%-31.06M-51.79%-7.19M
Net income continuous Operations 56.36%-2.6M54.42%-3.1M42.64%-4.14M6.41%-29.07M-26.51%-9.1M-4.01%-5.96M31.48%-6.79M12.24%-7.22M-114.68%-31.06M-51.79%-7.19M
Minority interest income
Net income attributable to the parent company 56.36%-2.6M54.42%-3.1M42.64%-4.14M6.41%-29.07M-26.51%-9.1M-4.01%-5.96M31.48%-6.79M12.24%-7.22M-114.68%-31.06M-51.79%-7.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 56.36%-2.6M54.42%-3.1M42.64%-4.14M6.41%-29.07M-26.51%-9.1M-4.01%-5.96M31.48%-6.79M12.24%-7.22M-114.68%-31.06M-51.79%-7.19M
Basic earnings per share 62.50%-0.1256.76%-0.1643.59%-0.227.69%-1.56-23.08%-0.48-3.23%-0.3231.48%-0.3713.33%-0.39-108.64%-1.69-44.44%-0.39
Diluted earnings per share 62.50%-0.1256.76%-0.1643.59%-0.227.69%-1.56-23.08%-0.48-3.23%-0.3231.48%-0.3713.33%-0.39-108.64%-1.69-44.44%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Broadcom
AVGO
+22.05%
Taiwan Semiconductor
TSM
+4.56%
Tesla
TSLA
+3.38%
ASML Holding
ASML
+0.63%
Apple
AAPL
-0.14%

Unlock the Full List